1. |
Zhao J, Ng SC, Lei Y, et al. First prospective, population- based inflammatory bowel disease incidence study in mainland of China: The emergence of "western" disease. Inflamm Bowel Dis 2013; 19:1839-45.
|
2. |
Ye L, Cao Q, Cheng J. Review of inflammatory bowel disease in China. Sci World J 2013; 14:296470.
|
3. |
Desai D, Patil S, Udwadia Z, et al. Pulmonary manifestations in inflammatory bowel disease: A prospective study. Indian J Gastroenterol 2011; 30:225-8.
|
4. |
Ateş F, Karincaoğlu M, Hacievlıyagıl SS, et al. Alterations in the pulmonary function tests of inflammatory bowel diseases. Turk J Gastroenterol 2011; 22:293-9.
|
5. |
Branch of Inflammatory bowel disease, Digestive Disease of Chinese Medical Association. Understanding the Consensus on Diagnosis and Management of Inflammatory Bowel Disease (Jinan, 2007). Chin J Dig 2007; 27:545-50.
|
6. |
Branch of Inflammatory bowel disease, Digestive Disease of Chinese Medical Association. Understanding the Consensus on Diagnosis and Management of Inflammatory Bowel Disease (Guangzhou, 2012). Chin J Intern Med 2012; 51:818-31.
|
7. |
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19:5-36.
|
8. |
D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroen- terology 2007; 132:763-86.
|
9. |
Mikhaĭlova ZF. Respiratory function in patients with chronic inflammatory bowel diseases. Eksp Klin Gastroen- terol 2009; 5:13-6.
|
10 |
Herrlinger KR, Noftz MK, Dalhoff K, et al. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002; 97:377-81.
|
11 |
Zhang W, Wang XY, Sun HY. Characteristics of injured lung function in patients with ulcerative colitis. J Beijing Univ Tradit Chin Med 2012; 35:213-6.
|
12 |
Shu W, Lu MM, Zhang Y, et al. Foxp2 and Foxp1 coop- eratively regulate lung and esophagus development. Development 2007; 134:1991-2000.
|
13 |
Yan X, Wang XY, Sheng YH, et al. Exploration of the theory of "Fei and Dachang being interior-exteriorly related" from observing changes of inflammatory cytokines and oxygen free radicals in the lung tissue of ulcerative colitis rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2014; 34:455-9.
|
14 |
Sheng YH, Wang XY, Yan X, et al. Discussion on theory of the lung and the large intestine being interior-exteriorly related from mechanism of apoptosis in lung injury in rats with ulcerative colitis. World Chin J Dig 2013; 21:1171-7.
|
15 |
Liu Y, Wang XY, Yang X, et al. Lung and intestine: A specific link in an ulcerative colitis rat model. Gastroenterol Res Pract 2013; 2013:124530.
|
16 |
Peradzyńska J, Krenke K, Lange J, et al. Low prevalence of pulmonary involvement in children with inflammatory bowel disease. Respir Med 2012; 106:1048-54.
|
17 |
Yadav PK, Liu Z. Current strategies for the treatment of ulcerative colitis. Recent Pat Inflamm Allergy Drug Discov 2009; 3:65-72.
|
18 |
Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007; 131:524-32.
|
19 |
Goeminne PC, Verschueren P, Scheers H, et al. Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: A retrospective and cohort analysis. Clin Rheumatol 2012; 31:367-73.
|
20 |
Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitis. Saudi J Gastroenterol 2012; 18:3-10.
|
21 |
Ng SC, Lam YT, Tsoi KK, et al. Systematic review: The efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38:854-63.
|
22 |
Dai YC, Tang ZP, Ma GT, et al. A review of Qingchang Shuan for treatment of ulcerative colitis. J Tradit Chin Med 2010; 30:237-40.
|